PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.](https://figures.cochat.ai/paper-figures/17d4ebdc4d0a46a99e4bb1385a64faa3/pink1-protects-against-oxidative-stress-by-phosphorylating-mitochondrial-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 1×
“Biochemical assays of cytochrome c release were performed as described [40].”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“served serine/threonine kinase domain [5].”
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Postmortem analyses reveal a deficiency in the mitochondrial complex I function in patients with sporadic PD [3].”
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“loss of PINK1 leads to mitochondrial defects and degeneration of muscle and dopaminergic neurons [”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“dopaminergic neurons [17–20].”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“In vitro kinase assays were performed as described [33] by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with TRAP1 for 20 min at 30 8C in 100 ll of reaction buffer containing 50 mM Tris-HCl (pH 7.”
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116 · cited 1×
“PC12 cells were treated with H2O2 as indicated, and cell viability was assessed using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described [38].”
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 1×
“of cellular processes, including cell survival and apoptosis [24, 25 ].”
Research works printed but not linked: 41
- Lang, 1998, N Engl J Med, 339, 1044
- Farrer, 2006, Nat Rev Genet, 7, 306
- Schapira, 1989, Lancet, 1, 1269
- Betarbet, 2002, Bioessays, 24, 308
- Valente, 2004, Science, 304, 1158
- Hatano, 2004, Ann Neurol, 56, 424
- Bonifati, 2005, Neurology, 65, 87
- Zadikoff, 2006, Mov Disord, 21, 875
- Hedrich, 2006, Arch Neurol, 63, 833
- Criscuolo, 2006, Mov Disord, 21, 1265
- Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
- Silvestri, 2005, Hum Mol Genet, 14, 3477
- Gandhi, 2006, Brain, 129, 1720
- Nakajima, 2003, Cancer Lett, 201, 195
- Petit, 2005, J Biol Chem, 280, 34025
- Deng, 2005, Biochem Biophys Res Commun, 337, 1133
- Clark, 2006, Nature, 441, 1162
- Park, 2006, Nature, 441, 1157
- Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
- Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
- Song, 1995, J Biol Chem, 270, 3574
- Chen, 1996, Mol Cell Biol, 16, 4691
- Felts, 2000, J Biol Chem, 275, 3305
- Beere, 2005, J Clin Invest, 115, 2633
- Muchowski, 2005, Nat Rev Neurosci, 6, 11
- Masuda, 2004, J Biol Chem, 279, 42503
- Sim, 2006, Hum Mol Genet, 15, 3251
- Olzmann, 2004, J Biol Chem, 279, 8506
- Chin, 2000, J Biol Chem, 275, 1191
- Choi, 2004, J Biol Chem, 279, 13256
- Choi, 2006, J Biol Chem, 281, 10816
- Chin, 2001, J Biol Chem, 276, 7069
- Ninomiya-Tsuji, 1999, Nature, 398, 252
- Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
- Li, 2002, J Biol Chem, 277, 28212
- Hovius, 1990, Biochim Biophys Acta, 1021, 217
- Kirk, 2006, J Cell Sci, 119, 4689
- Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
- Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
- Yang, 1997, Science, 275, 1129
- Sherer, 2002, J Neurosci, 22, 7006
Cited by
Items 301–400 of 596
Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinsons Disease
Arduino, D., Esteves, A., Oliveira, C., & Cardoso, S. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966687 · Cited by 44
“PINK1 has a role in cellular protection against oxidative stress [115] and affects mitochondrial dynamics and morphology in cooperation with mitochondrial fusion/ fission proteins [116].”
Basit, F., & de Vries, I. J. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02386 · Cited by 48
Loss-of-Function Rodent Models for Parkin and PINK1
Oliveras-Salv´, M., Van Rompuy, A.-S., Heeman, B., Van den Haute, C., & Baekelandt, V. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11041 · Cited by 43
“In addition, PINK1 has been shown to confer protection against hydroxyl radicals (H2O2) [136, 137].”
BackgroundParrado‐Fernández, C., Schreiner, B., Ankarcrona, M., Conti, M. M., Cookson, M. R., Kivipelto, M., Cedazo-Mínguez, Á., & Matton, A. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13815 · Cited by 44
Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1)
Sim, C. H., Gabriel, K., Mills, R. D., Culvenor, J. G., & Cheng, H. (2012) · Human Mutation · doi:10.1002/humu.22127 · Cited by 48
“…products with molecular sizes ranging from 60 to 45 kDa [Greene et al., 2012; Jin et al., 2010; Michiorri et al., 2010; Muqit et al., 2006; Petit et al., 2005; Pridgeon et al., 2007; Rakovic et al., 2010; Sha et al., 2010; Silvestri et al., 2005; Takatori et al., 2008; Weihofen et al., 2008].”
BackgroundInfluentialde Menezes, J. P. B., de Almeida, T. F., Petersen, A. L. O. A., Guedes, C. E. S., Mota, M. S., Lima, J. G. B., Palma, L. C., Buck, G. A., Krieger, M. A., Probst, C., et al. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.04.005 · Cited by 42
“TRAP1 is associated with the maintenance of cellular viability under H2O2 -induced oxidative stress [48] in addition to Serpin, another protein induced through TNF-a, which participates in the cascade of inflammation together with IL-1a [49].”
BackgroundCorrelation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer
Gao, J., Song, B., Peng, J.-J., & Lu, Y.-M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5965 · Cited by 47
Azkona, G., de Maturana, R. L., del Río, P., Sousa, A., Vázquez, N., Zubiarrain, A., Jiménez-Blasco, D., Bolaños, J. P., Morales, B., Auburger, G. W. J., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0303-7 · Cited by 41
“Analysis of proteins involved in fusion and fission mitochondrial dynamics in PD fibroblasts showed alterations that are consistent with activation of compensatory mechanisms in the mutants but could also reflect a defective inhibition of fission through TRAP1 [31, 32].”
BackgroundO'Rourke, B. P., Eyk, J. E. V., & Foster, D. B. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00266.x · Cited by 44
Coexistence of mutations in PINK1 and mitochondrial DNA in early onset parkinsonism
Piccoli, C., Ripoli, M. C., Quarato, G., Scrima, R., D’Aprile, A., Boffoli, D., Margaglione, M., Criscuolo, C., Michele, G. D., Sardanelli, A. M., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058628 · Cited by 44
“[5] In addition, the protease HtrA2 has also been shown to be regulated by PINK1 but through an indirect phosphorylation mechanism.”
BackgroundRegulation of PINK1 by NR2B‐containing NMDA receptors in ischemic neuronal injury
Shan, Y., Liu, B., Li, L., Chang, N., Li, L., Wang, H., Wang, D., Feng, H., Cheung, C. C., Liao, M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06398.x · Cited by 43
Self-citationPINK1 as a Molecular Checkpoint in the Maintenance of Mitochondrial Function and Integrity
Koh, H., & Chung, J. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0100-8 · Cited by 40
Kim, H., Yang, J., Kim, M. J., Choi, S., Chung, J.-R., Kim, J.-M., Yoo, Y. H., Chung, J., & Koh, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.656934 · Cited by 40
“(15) reported that phosphorylation of TRAP1 by PINK1 is responsible for protecting neuroendocrine tumor-derived PC-12 cells from reactive oxygen species (ROS).”
BackgroundCross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease
Gumeni, S., & Trougakos, I. P. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4587691 · Cited by 48
“TRAP1 is phosphorylated by PINK1 protein (see below) to promote cell survival [44].”
BackgroundZhao, X., Sun, K., Lan, Z., Song, W., Cheng, L., Chi, W., Chen, J., Huo, Y., Xu, L., Liu, X., et al. (2017) · Scientific Reports · doi:10.1038/srep46344 · Cited by 42
Joshi, A., Ito, T., Picard, D., & Neckers, L. (2022) · Biomolecules · doi:10.3390/biom12070880 · Cited by 43
The complex interplay between autophagy and cell death pathways
Ploumi, C., Papandreou, M.-E., & Tavernarakis, N. (2022) · Biochemical Journal · doi:10.1042/bcj20210450 · Cited by 39
Mitochondrial chaperone TRAP1 activates the mitochondrial UPR and extends healthspan in Drosophila
Baqri, R. M., Pietron, A. V., Gokhale, R. H., Turner, B. A., Kaguni, L. S., Shingleton, A. W., Kunes, S. M., & Miller, K. E. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.09.002 · Cited by 39
“Given previous work implicating TRAP1 in Parkinson’s disease via its interaction with PINK1 (Pridgeon et al., 2007; Costa et al., 2013; Zhang et al., 2013) and a-synuclein (Butler et al., 2012), these data indicate that augmenting TRAP1 expression in the nervous tissue may be beneficial in human…”
BackgroundInfluentialTRAP1 Controls Mitochondrial Fusion/Fission Balance through Drp1 and Mff Expression
Takamura, H., Koyama, Y., Matsuzaki, S., Yamada, K., Hattori, T., Miyata, S., Takemoto, K., Tohyama, M., & Katayama, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051912 · Cited by 39
“Recently, TRAP1 was reported as a downstream phosphorylation target of PTEN-induced kinase 1 (PINK1), a gene involved in the onset of Parkinson’s disease, in rat and human cell lines [60].”
BackgroundAnalysis of neuronal phosphoproteome reveals PINK1 regulation of BAD function and cell death
Wan, H., Tang, B., Liao, X., Zeng, Q., Zhang, Z., & Liao, L. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0027-x · Cited by 41
Role of neddylation in neurological development and diseases
He, X., Zhu, A., Feng, J., & Wang, X. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2112 · Cited by 40
“Although PINK1-mediated protein phosphorylation is not well understood, several potential substrates of PINK1 have been identified [96, 97].”
BackgroundTargeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives
Serapian, S. A., Sànchez‐Martìn, C., Moroni, E., Rasola, A., & Colombo, G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.04.003 · Cited by 39
Papa, S., Petruzzella, V., Scacco, S., Sardanelli, A. M., Iuso, A., Panelli, D., Vitale, R., Trentadue, R., Rasmo, D. D., Capitanio, N., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.12.018 · Cited by 46
Veras, P. S. T., & de Menezes, J. B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081270 · Cited by 39
“TRAP1 has been shown to participate in the maintenance of cellular viability in cells subjected to H2O2-induced oxidative stress [60], and Serpin, a protein induced by TNF-α known to participate in conjunction with IL-1α in the inflammatory cascade [61].”
BackgroundFallaize, D., Chin, L., & Li, L. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.09.020 · Cited by 40
“These methodological limitations may contribute to the conflicting conclusions on PINK1 submitochondrial localization: several studies, including ours, showed that PINK1 is localized in the IMM and IMS with its kinase domain facing the IMS [24,28,25,23,26], whereas others reported that PINK1 resides on the OMM with it…”
BackgroundResultSelf-citationChien, W.-L., Lee, T.-R., Hung, S.-Y., Kang, K.-H., Lee, M.-J., & Fu, W.-M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07229.x · Cited by 38
Sànchez‐Martìn, C., Serapian, S. A., Colombo, G., & Rasola, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01177 · Cited by 39
Bus, C., Zizmare, L., Feldkaemper, M. P., Geisler, S., Zarani, M., Schaedler, A., Klose, F., Admard, J., Mageean, C. J., Arena, G., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101797 · Cited by 44
Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases
Shen, J. (2010) · Neurodegenerative Diseases · doi:10.1159/000285511 · Cited by 38
The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics
Thomas, K. J., & Cookson, M. R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.018 · Cited by 38
PINK1 signaling in mitochondrial homeostasis and in aging (Review)
Kitagishi, Y., Nakano, N., Ogino, M., Ichimura, M., Minami, A., & Matsuda, S. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2827 · Cited by 38
“PINK1 phosphorylates a mitochondrial molecular chaperone heat shock protein 75 (Hsp75), also known as mitochondrial heat shock protein 75 kDa [or tumor necrosis factor receptorassociated protein 1 (TRAP1)], which increases neuronal survival withstanding oxidative stress or heat shock by inhibiting the release of cytoc…”
BackgroundAging Disrupts the Circadian Patterns of Protein Expression in the Murine Hippocampus
Adler, P., Chiang, C., Mayne, J., Ning, Z., Zhang, X., Xu, B., Cheng, H. M., & Figeys, D. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00368 · Cited by 38
Structural determinants of PINK1 topology and dual subcellular distribution
Lin, W., & Kang, U. J. (2010) · BMC Cell Biology · doi:10.1186/1471-2121-11-90 · Cited by 38
“The submitochondrial localization of PINK1, by biochemical fractionation, shows that all forms of PINK1 are found at the outer membrane, intermembrane space, and inner membrane, but not the matrix [8,10].”
BackgroundRusso, A., Cirulli, C., Amoresano, A., Pucci, P., Pietropaolo, C., & Russo, G. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.08.006 · Cited by 37
Flies with Parkinson's disease
Vanhauwaert, R., & Verstreken, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.020 · Cited by 39
Nitric Oxide Induction of Parkin Translocation in PTEN-induced Putative Kinase 1 (PINK1) Deficiency
Han, J., Kang, M., Kim, K., Han, P., Kim, H., Ha, J., & Son, J. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624767 · Cited by 38
“In contrast, overexpression of the L347P mutant, having reduced kinase activity (43, 44) and loss of interaction with Hsp90/Cdc37 chaperones (45), could not help significantly in the recovery from the loss of phosphonNOS accumulation (Fig.”
BackgroundHILAQ: A Novel Strategy for Newly Synthesized Protein Quantification
Ma, Y., McClatchy, D. B., Barkallah, S., Wood, W. W., & Yates, J. R. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00005 · Cited by 37
Yu, X., Man, R., Li, Y., Yang, Q., Li, H., Yang, H., Bai, X., Yin, H., Li, J., & Wang, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14379 · Cited by 36
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
Kincses, Z. T., & Vécsei, L. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00150.x · Cited by 45
“Alternatively, failing physiological phosphorylation triggers a signaling cascade that opens the mitochondrial transition pores and apoptosis commences [160,161].”
BackgroundWu, F., Wang, P., Zhang, J., Young, L. C., Lai, R. L., & Li, L. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m000153-mcp201 · Cited by 42
“mitochondria under oxidative stress (69).”
Self-citationPINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage
Lambourne, O. A., Bell, S., Wilhelm, L. P., Yarbrough, E. B., Holly, G. G., Russell, O. M., Alghamdi, A. M., Fdel, A. M., Varricchio, C., Lane, E. L., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00555 · Cited by 40
Role of the unfolded protein response in the pathogenesis of Parkinson’s disease
Varma, D. V. S. N. S., & Sen, D. (2015) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2015-2012 · Cited by 37
“PINK1 interacts with several proteins involved with the MT-UPR and MT quality control including TRAP1 (Pridgeon et al. 2007), HSP60 (Rakovic et al.”
BackgroundIm, C. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0687-3 · Cited by 35
Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1
Amo, T., Saiki, S., Sawayama, T., Sato, S., & Hattori, N. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.045 · Cited by 37
PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation
Lee, H. J., & Chung, K. C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-271 · Cited by 34
“Furthermore, PINK1 exerts its cytoprotective function in the mitochondria as well as in the cytoplasm through activation of mTORC2 and Akt [40].”
Ali, M. Z., & Dholaniya, P. S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105344 · Cited by 34
Animal models of mitochondrial DNA transactions in disease and ageing
Oliveira, M. T., Garesse, R., & Kaguni, L. S. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.019 · Cited by 42
Lee, H. J., Jang, S. H., Kim, H., Yoon, J., & Chung, K. C. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1004-7 · Cited by 37
“Nonetheless, recombinant PINK1 directly phosphorylates TRAP1 in vitro, and PINK1 overexpression enhances H2O2-induced TRAP1 phosphorylation in PC12 cells [5].”
BackgroundGenome-wide screen for modifiers of Parkinson's disease genes in Drosophila
Fernandes, C., & Rao, Y. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-17 · Cited by 38
“Pink1 is a mitochondria-localized serine/threonine kinase [2,12,13].”
BackgroundMitochondria and the permeability transition pore in cancer metabolic reprogramming
Guo, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114537 · Cited by 35
Correction: Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
Siddall, H. K., Yellon, D. M., Ong, S., Mukherjee, U., Burke, N., Hall, A. R., Angelova, P. R., Ludtmann, M. H. R., Deas, E., Davidson, S. M., et al. (2013) · PLoS ONE · doi:10.1371/annotation/94fd6502-4b2d-409c-8836-66fe6ebc03ab · Cited by 34
Mitochondrial Kinases and the Role of Mitochondrial Protein Phosphorylation in Health and Disease
Kotrasová, V., Keresztesová, B., Ondrovičová, G., Bauer, J., Havalová, H., Pevala, V., Kutějová, E., & Kunová, N. (2021) · Life · doi:10.3390/life11020082 · Cited by 38
Prostate cancer regulatory networks
Altieri, D. C., Languino, L. R., Lian, J. B., Stein, J. L., Leav, I., van Wijnen, A. J., Jiang, Z., & Stein, G. S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22162 · Cited by 34
“…a general cytoprotective function of mitochondrial Hsp90 chaperones, including TRAP-1, and established their role in inhibition of cytochrome c release [Masuda et al., 2004], and suppression of apoptosis [Hua et al., 2007], especially in response to oxidative stress [Pridgeon et al., 2007].”
BackgroundOxidative Stress and Regulation of Pink1 in Zebrafish (Danio rerio)
Priyadarshini, M., Orosco, L. A., & Panula, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081851 · Cited by 34
“Pink1 overexpression protects cells against oxidative stress, which is achieved by TRAP1 phosphorylation [38].”
BackgroundProgrammed cell death and new discoveries in the genetics of parkinsonism
Burke, R. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05106.x · Cited by 37
Does perturbation in the mitochondrial protein folding pave the way for neurodegeneration diseases?
Ji, T., Zhang, X., Xin, Z., Xu, B., Jin, Z., Wu, J., Hu, W., & Yang, Y. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100997 · Cited by 29
Faienza, F., Lambrughi, M., Rizza, S., Pecorari, C., Giglio, P., Viloria, J. S., Allega, M. F., Chiappetta, G., Vinh, J., Pacello, F., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113869 · Cited by 31
Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement
Matsui, H., Taniguchi, Y., Inoue, H., Kobayashi, Y., Sakaki, Y., Toyoda, A., Uemura, K., Kobayashi, D., Takeda, S., & Takahashi, R. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.10.010 · Cited by 31
“One of the putative substrates of the kinase is TNF receptor-associated protein 1 (TRAP1), though its biological significance remains elusive (Pridgeon et al., 2007).”
BackgroundMitochondrial dysfunction in Parkinson’s disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750811040032 · Cited by 30
Trudler, D., Nash, Y., & Frenkel, D. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1399-z · Cited by 32
“PINK1 has been shown to protect cells against oxidative stress (Deas et al. 2009) by phosphorylating the mitochondrial protein TRAP1 (chaperone tumor necrosis factor receptor-associated protein 1) (Pridgeon et al. 2007).”
BackgroundDictyostelium, a microbial model for brain disease
Annesley, S. J., Chen, S., Francione, L. M., Sanislav, O., Chavan, A. J., Farah, C., Piazza, S. W. D., Storey, C., Ilievska, J., Fernando, S., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.019 · Cited by 37
Mitochondrial Morphogenesis, Distribution, and Parkinson Disease: Insights From PINK1
Yang, Y., & Lu, B. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b2048c · Cited by 34
“First, a mitochondrial molecular chaperone TRAP1 (also called heat shock protein 75) was shown to be phosphorylated by Pink1 in cell culture (69).”
BackgroundThe impact of genetic research on our understanding of Parkinson’s disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83002-x · Cited by 36
“Additionally, recent in vivo data suggest that phosphorylation of the mitochondrial chaperone TNF-receptor-asso ciated protein 1(TRAP1) by PINK1 is important for the protective action of PINK1 against oxida tive stress-induced cell death (Pridgeon et al., 2007).”
BackgroundTiwari, S., Singh, A., Gupta, P., & Singh, S. (2022) · Cells · doi:10.3390/cells11233770 · Cited by 34
“Mitochondrial chaperone, HSP75/TRAP1, regulates the formation of reactive oxygen species (ROS) and shows an explicit connection with PINK1, wherein PINK1 phosphorylates HSP75 to protect the neuronal cells against oxidative stress [72].”
BackgroundVerma, M., Zhu, J., Wang, K. Z. Q., & Chu, C. T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010474 · Cited by 29
PAN-AMPK Activation Improves Renal Function in a Rat Model of Progressive Diabetic Nephropathy
Zhou, X., Muise, E. S., Haimbach, R. E., Sebhat, I. K., Zhu, Y., Liu, F., Souza, S. C., Kan, Y., Pinto, S., Kelley, D. E., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258244 · Cited by 30
Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Lyakhovich, A., & Graifer, D. M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150729114036 · Cited by 29
Mora, R. M. S., Arboleda, H., & Arboleda, G. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9687-z · Cited by 29
Mitophagy in Neurodegeneration: An Opportunity for Therapy?
Santos, R. X., Correia, S. C., Carvalho, C., Cardoso, S., Santos, M. S., & Moreira, P. I. (2011) · Current Drug Targets · doi:10.2174/138945011795528813 · Cited by 30
Late onset sporadic Parkinson's disease caused by PINK1 mutations: Clinical and functional study
Gelmetti, V., Ferraris, A., Brusa, L., Romano, F., Lombardi, F., Barzaghi, C., Stanzione, P., Garavaglia, B., Dallapiccola, B., & Valente, E. M. (2008) · Movement Disorders · doi:10.1002/mds.21960 · Cited by 28
Im, C., & Seo, J. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.5.174 · Cited by 27
“H2O2 and granzyme M, by regulating ROS accumulation during apoptosis (17, 18, 20).”
BackgroundBellizzi, D., Taverna, D., D’Aquila, P., Blasi, S. D., & BENEDICTIS, G. D. (2008) · Cell Stress and Chaperones · doi:10.1007/s12192-008-0081-x · Cited by 30
“HSP75 acts as an antagonist of ROS and exhibits anti-apoptotic activity (Hua et al. 2007; Pridgeon et al. 2007).”
BackgroundMolecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
Lallier, M., Marchandet, L., Moukengué, B., Charrier, C., Baud’huin, M., Verrecchia, F., Ory, B., & Lamoureux, F. (2021) · Cells · doi:10.3390/cells10040754 · Cited by 30
Szalárdy, L., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/498401 · Cited by 37
“In addition to parkin, tumor necrosis factor (TNF) receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), has been postulated to be another possible downstream target of PINK1, through which PINK1 activity can prevent the release of cytochrome c and a su…”
BackgroundMitochondrial drug targets in neurodegenerative diseases
Lee, J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.032 · Cited by 26
HSP75 protects against cardiac hypertrophy and fibrosis
Zhang, Y., Jiang, D., Yan, L., Cheng, K., Bian, Z., & Lin, G. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23091 · Cited by 26
“There is increasing evidence for the involvement of HSP75 in responses to various environmental stresses, including glucose deprivation, oxidative injury, and ultraviolet A irradiation [Hua et al., 2007; Pridgeon et al., 2007; Voloboueva et al., 2008; Xu et al., 2009].”
BackgroundMolecular Mechanisms of PINK1-Related Neurodegeneration
Pogson, J. H., Ivatt, R. M., & Whitworth, A. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0187-x · Cited by 30
Yoo, L., & Chung, K. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.803890 · Cited by 27
“Previous reports revealed that PINK1 exerts a cytoprotective effect against various physical and chemical insults in mammalian cells (7, 20, 21).”
BackgroundNew insights into the structure of PINK1 and the mechanism of ubiquitin phosphorylation
Rasool, S., & Trempe, J. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1491525 · Cited by 27
“…optimization, co-expression with TRAP1—a mitochondrial chaperone and proposed interaction partner of PINK1 (Beilina et al. 2005; Sim et al. 2006; Pridgeon et al. 2007; Hertz et al. 2013), or secretion in Pichia pastoris (Wu et al. 2016). hPINK1 produced from orthologous systems also exhibits…”
BackgroundThe Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
Dekker, F. A., & Rüdiger, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.697913 · Cited by 28
PINK1 alleviates myocardial hypoxia-reoxygenation injury by ameliorating mitochondrial dysfunction
Li, Y., Qiu, L., Liu, X., Hou, Z., & Yu, B. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.061 · Cited by 26
Fichi, G., Naef, V., Barca, A., Longo, G., Fronte, B., Verri, T., Santorelli, F. M., Marchese, M., & Petruzzella, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102409 · Cited by 29
“PINK1 is a ubiquitously expressed protein with an N-terminal mitochondrial-targeting motif and a conserved serine⁄threonine kinase domain, and two of its targets have been identified: TNF receptor-associated protein 1, which protects against oxidative stress [87], and DRP1, which promotes mitochondrial fission [88].”
BackgroundMatić, I., Strobbe, D., Frison, M., & Campanella, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.021 · Cited by 23
New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments
Li, X., Li, Y., Shi, Z., & Guo, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117737 · Cited by 21
Targeting Mitochondrial Protein Expression as a Future Approach for Cancer Therapy
Criscuolo, D., Avolio, R., Matassa, D. S., & Esposito, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.797265 · Cited by 23
Mitochondrial-Dependent and Independent Functions of PINK1
Chen, X., Wang, Q., Li, S., Li, X., & Yang, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.954536 · Cited by 31
Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells
Matassa, D. S., Criscuolo, D., Avolio, R., Agliarulo, I., Sarnataro, D., Pacelli, C., Scrima, R., Colamatteo, A., Matarese, G., Capitanio, N., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02788-4 · Cited by 22
“Upstream signaling potentially responsible for this regulation also needs further research, but it has been already demonstrated that TRAP1 can be subject to diverse post-translational modification modulating its activity [32, 33], one of those being mediated by the PINK1 kinase [34], whose loss also cause dysregulati…”
BackgroundCasas-Benito, A., Martínez-Herrero, S., & Martínez, A. (2023) · Cancers · doi:10.3390/cancers15102862 · Cited by 31
“TRAP-1 is also crucial in some other pathologies such as Parkinson disease, as a mutation in PTEN-induced Putative Kinase (PINK1), which phosphorylates and activates TRAP-1, is present in the disease, where PINK1-mutated cells cannot activate TRAP-1 and apoptosis occurs [206].”
BackgroundThe mitochondrial kinase PINK1, stress response and Parkinson’s disease
Jendrach, M., Gispert, S., Ricciardi, F., Klinkenberg, M., Schemm, R., & Auburger, G. W. J. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9256-0 · Cited by 29
“Conversely, overexpression of PINK1 in the neuronal cell line PC12 protected cells against oxidative stress induced apoptosis, an effect mediated by the direct phosphorylation of TRAP1 (TNF receptor-associated protein 1) by PINK1 (Pridgeon et al. 2007).”
BackgroundKinase signaling pathways as potential targets in the treatment of Parkinson’s disease
Greggio, E., & Singleton, A. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.6.783 · Cited by 24
A Novel Non‐Apoptotic Role of Procaspase‐3 in the Regulation of Mitochondrial Biogenesis Activators
Kim, J., Ha, J., Yang, S., & Son, J. H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26186 · Cited by 26
“, 2010], whereas overexpression of the wild type form of the recessive mutant PD genes, such as parkin and PINK1, demonstrated a protective effect against PCD [Darios et al., 2003; Valente et al., 2004; Petit et al., 2005; Pridgeon et al., 2007; Berger et al., 2009].”
BackgroundInfluentialMechanisms of neurodegeneration in Parkinson’s disease: keep neurons in the PINK1
Brunelli, F., Valente, E. M., & Arena, G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111277 · Cited by 23
Parkinson's Disease: From Genetics to Treatments
Fan, H., Chen, S., Harn, H., & Lin, S. (2013) · Cell Transplantation · doi:10.3727/096368912x655082 · Cited by 26
Mitophagy in the aging nervous system
Rappe, A., & McWilliams, T. G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.978142 · Cited by 23
“, 2022), and a vast body of literature demonstrates supraphysiological ROS generation promotes cell dysfunction (Lennicke and Cochemé, 2021), also reported for cells and tissues with dysfunctional PINK1/Parkin signalling (Hoepken et al., 2007; Pridgeon et al., 2007; Anichtchik et al., 2008; Narendra et al., 2010; Priy…”
BackgroundMitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease
Yadav, A., Agarwal, S., Tiwari, S. K., & Chaturvedi, R. K. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224545 · Cited by 23
Fei, X., Ma, S., Lv, Y., Zhang, D., Song, H., & Huang, Y. (2019) · Burns & Trauma · doi:10.1186/s41038-019-0154-3 · Cited by 22
“On the other hand, TRAP1 knockdown in tumor cells induces Cyt c releasing from mitochondria into the cytosol and promotes apoptosis, whereas TRAP1 overexpression markedly attenuates the damage induced by oxidative stress and preserves the function of tumor cells [28, 29].”
BackgroundHeat Shock Protein 90 Inhibitors as Therapeutic Agents
Gomez-Monterrey, I. M., Sala, M., Musella, S., & Campiglia, P. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489212801820066 · Cited by 23
Pattarini, R., Rong, Y., Qu, C., & Morgan, J. I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.064 · Cited by 25
“Its lower levels in SWR mice seems at odds with the suggested pro-survival effect of Pink1 in PD (Abeliovich, 2007, Pridgeon et al., 2007).”
BackgroundAbeliovich, A. (2007) · Nature · doi:10.1038/448759a · Cited by 22
Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells
Maj, M. C., Tkachyova, I., Patel, P., Addis, J., MacKay, N., Levandovskiy, V., Lee, J., Lang, A. E., Cameron, J. M., & Robinson, B. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.033 · Cited by 21
Metadata
- Authors
- Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Chin, Lih-Shen
- Li, Lian
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-06-19
- Volume
- 5
- Issue
- 7
- Pages
- e172
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC1892574
- OpenAlex
- W2055538245
- Cited by
- 596
- References
- 44
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
- FWCI
- 42.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG021489, R01AG021489)
- National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.